-
Long-term Data in Patients with Metastatic Non-Small Cell Lung Cancer Harboring MET Exon 14 Skipping Alterations
07 Jun 2024 20:35 GMT
… such as metastatic non-small cell lung cancer (NSCLC).1 Tepotinib … patients with metastatic non-small cell lung cancer (NSCLC) harboring … advances in non-small cell lung cancer targeted therapy; an … Tepotinib in non-small-cell lung cancer with MET exon 14 …
-
Amplity Health Study Identifies Major Gaps in Biomarker Testing and Targeted Therapy Use In Non-Small Cell Lung Cancer in the United States
07 Jun 2024 20:13 GMT
… testing for patients with non-small cell lung cancer (NSCLC) in the United States … Use Among Patients With Non-Small Cell Lung Cancer in the United States: An … -targeted-therapy-use-in-non-small-cell-lung-cancer-in-the-united-states-302167326 …
-
Positive results in lung cancer show benefits of subcutaneous bispecifics
07 Jun 2024 18:09 GMT
… or L858R-mutated advanced non-small cell lung cancer and disease progression on osimertinib …
-
Adagrasib delays progression of pretreated KRAS-mutant lung cancer
07 Jun 2024 18:08 GMT
… locally advanced or metastatic non-small cell lung cancer, according to researchers.
Data … with KRASG12C-mutated [non-small cell lung cancer] after disease progression on … previously treated KRASG12C-mutated non-small cell lung cancer in the phase 1…
-
Low-fat diet associated with lower risk of lung cancer especially in smokers: Study
07 Jun 2024 16:13 GMT
… adherence and lung cancer incidence, including non-small cell lung cancer (NSCLC) and small cell lung cancer (SCLC).
The … components intake, and incident lung cancer. Restricted cubic spline analyses … fatty acids intake and lung cancer incidence.
The study …
-
Development and Validation of Nomograms for Predicting Pneumonia in Patients with COVID-19 and Lung Cancer
07 Jun 2024 13:20 GMT
… or cytologically confirmed lung cancer (tumor stage and … L1 Therapy in Non-Small-Cell Lung Cancer. Front Immunol. 2022 … 19 and lung cancer: a greater fatality rate? Lung Cancer. 2020; … the treatment of non-small-cell lung cancer: a secondary analysis …
-
ASCO: Ivonescimab Improves Progression-Free Survival in EGFR+ Lung Cancer
07 Jun 2024 07:13 GMT
… ) — For patients with non-small cell lung cancer with the epidermal growth factor … relapsed advanced or metastatic non-small cell lung cancer with the EGFR variant … survival in patients with non-small cell lung cancer whose disease progressed while receiving …
-
Dr Spigel on the Efficacy of Durvalumab Consolidation Therapy in LS-SCLC
07 Jun 2024 20:35 GMT
… ) in patients with limited-stage small cell lung cancer (LS-SCLC).
ADRIATIC evaluated durvalumab (Imfinzi … therapy in patients with LS-SCLC who had received prior concurrent …
-
Ground-glass opacities on CT lung cancer imaging encouraging prognostic factor in non-small cell lung cancer: Study
05 Jun 2024 18:54 GMT
… in clinical Stage I non–small cell lung cancer (NSCLC). The research explores the … insights for managing early-stage lung cancer.
The study found the presence … encouraging prognostic factor in non-small cell lung cancer.
"Minor-GGO elements on …
-
Durvalumab extends survival in limited-stage small-cell lung cancer
04 Jun 2024 18:25 GMT
… in patients with limited-stage small-cell lung cancer following standard-of-care … types of lung cancer, and warranted research in limited-stage small-cell lung cancer.
The ADRIATIC … know small-cell lung cancers are really different types of lung cancers, so I …